NYSE · OWLT
Healthcare · Medical - Devices
$5.21▼ 0.57% ($0.03)today
As of 11:59 AM ET
Market cap
$94.27M
P/E
-12.12
EPS (TTM)
-$0.32
Next earnings
Nov 12, 2026
Valuation
A cash-flow estimate wouldn't be reliable here
7 of 10 projected years produce negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.
USD · TTM ending Jun 30, 2026 · Price used $5.21 · Price Sep 30, 3:59 PM UTC
USD · TTM ending Jun 30, 2026 · Price used $5.21 · Price Sep 30, 3:59 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
The stock fell 38.49% over the last year. Revenue grew 27.96% over the trailing twelve months. Operating margin moved from -18.61% to -6.45%. Free cash flow grew 30.15% over the trailing twelve months.
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
This read changes if operating margin (currently -6.45%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Owlet, Inc. is a U.S.-based company that provides a digital platform specifically designed to support parents.
Market multiples
Stock splits
Every 14 shares became 1
Profitability & growth
Analyst consensus
4
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 12, 2026
Q3 FY26 · EPS est -$0.04 · Revenue est $29.96M
View
Owlet, Inc. · OWLT
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.